# Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

Study · id `cardio:ct-nct02089464` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02089464](<https://clinicaltrials.gov/study/NCT02089464>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02089464

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 199 participants.

## Technical summary

Registry record NCT02089464. Randomized; triple masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2016-05 (actual). Results posted on 2020-09-01.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 199 participants (enrolled count; ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Start date: 2014-04 (registry gives no type) (ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Primary completion: 2016-05 (actual) (ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Completion: 2016-05 (actual) (ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Results first posted: 2020-09-01 (ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02089464, source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02089464-2020-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial
- Acronym: NICHE
- Condition: Stroke
- Intervention (Device): NBS-guided rTMS
- Intervention (Device): Sham rTMS
- Intervention (Procedure): Task oriented rehabilitation
- Lead sponsor: Nexstim Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke (`cardio:pubmed-30354990`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0b1b4d3492246081231c686ccd612425dc93682c93f52f5481c2839fd5dc61d4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
